Beranda › Kanker Ovarium › Distrik Columbia
Uji klinis Kanker Ovarium di Distrik Columbia
7 studi untuk Kanker Ovarium mencari peserta di lokasi di Distrik Columbia.
Kota di Distrik Columbia
Teks studi resmi (Bahasa Inggris)
A Study of Raludotatug Deruxtecan With or Without Bevacizumab as First-Line Maintenance Treatment in Non-HRD-Positive Advanced Ovarian Cancer (MK-5909-006, (ENGOT-ov102/GOG-3141/ REJOICE-Ovarian 04)
- MedStar Washington Hospital Center ( Site 0026), Washington D.C.
Menerima pesertaFase 3
Usia 18 ke atas · Wanita · Diperbarui 24 Sep 2026 · NCT07776691Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Georgetown University Medical Center, Washington D.C.
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT05983432A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- Medstar Georgetown University Hospital, Washington D.C.
Menerima pesertaFase 2
Usia 18 hingga 99 · Wanita · Diperbarui 15 Sep 2026 · NCT07023627Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's National Medical Center, Washington D.C.
Menerima pesertaFase 1/2
12 Months – 30 Years · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT04851119A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Washington D.C.
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT07182149Cancer Experience Registry (CER) for Cancer Patients and Caregivers
- Cancer Support Community Research & Training Institute, Washington D.C.
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Apr 2026 · NCT02333604CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
Menerima pesertaSukarelawan sehat diterima
Usia 18 ke atas · Wanita · Diperbarui 28 Agu 2025 · NCT05130606Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.